Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
More than 70% of people treated with Abecma, a customized immunotherapy, experienced complete or partial remission.
Acupuncture was associated with a steeper and more sustained reduction in chronic pain for cancer survivors than pain medications.
The kinase inhibitor delayed disease progression by 27% for people who had tried at least two prior therapies.
People with head and neck cancer who are worried about the cost of treatment are about twice as likely to die as people who are not.
Study participants who received Libtayo had a 31% lower risk of death than those treated with chemotherapy.
Opdivo plus Cabometyx reduced the risk of death by 40%.
The CAR-T therapy led to complete remission in 60% of people with relapsed or refractory follicular lymphoma.
The targeted therapy delayed disease progression in people with advance non-small-cell lung cancer, including those with brain metastasis.
The checkpoint inhibitor delayed disease progression and improved overall survival in non-small-cell lung cancer patients.
Cancer patients who began palliative care earlier were more likely to receive supportive home care in the last month of their lives.
Study finds that ide-cel produces remissions in almost 75% of patients with multiple myeloma who had relapsed after previous treatments.
Hayley Arceneaux, who survived pediatric cancer, hopes her pioneering journey will inspire other patients.
You don’t have to lift heavy weights or do interval training to decrease side effects related to cancer treatment.
New research shows that gene activity could be used to predict tumors most likely to benefit from “genotoxic” therapies
Cancer and its treatment can have severe side effects that can affect employment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.